Peter Davey

Peter Davey is an experienced professional in the field of polysaccharide development and manufacturing, currently serving as Executive Director at Vaxcyte since May 2017. With a robust background that includes leadership roles such as Senior Director and Director, Peter has successfully managed teams and overseen substantial budgets for development and manufacturing projects. Notable accomplishments include the creation of a standardized manufacturing process for a 24-valent pneumococcal conjugate vaccine and the optimization of upstream and downstream processes, which have resulted in significant yields. Prior experience includes roles at Juno Therapeutics and Inventprise, where Peter led various process development initiatives. Educational qualifications include a Master of Science in Biological Systems Engineering and a Bachelor of Science in Biochemistry and Molecular Biology from Washington State University and Colorado State University, respectively.